Healthcare marketing for healthtech: growing in a regulated care market

Healthtech is one of the hardest markets to grow in. Your product may be clinically superior, but the road from first interest to signed contract runs through long adoption cycles, hard requirements around clinical validation and a room full of decision-makers who each want to hear something different. Isolated tactics do not survive here. What does work is a system that removes each point of friction, step by step. This article shows how growth-led healthcare marketing becomes that system for healthtech companies in the Benelux.

This is a deep dive within our cluster on what growth marketing is. Read that first if you want the broader framework; here we focus specifically on the care context. If you work in another heavily regulated market, you will recognise many of these principles in growth marketing for fintech.

Why healthtech is different from ordinary B2B

In most B2B markets, a sales cycle of a few months is already substantial. In healthtech, that is closer to the floor. A hospital, care group or insurer does not buy software because a landing page converts well. They buy because the product made it through pilots, audits, legal review and budget cycles without stumbling anywhere.

That has three consequences for your growth approach. One: you cannot force trust, you have to build it over a long period. Two: your burden of proof is higher than in almost any other sector, because it involves patient safety and sensitive data. Three: the person who gets excited about your product is almost never the one who signs. A growth system for healthtech has to account for all three at once.

Many care technology companies try to solve this with more leads at the top of the funnel. Understandable, but it is the wrong lever. The problem is rarely too little interest; it sits in the journey afterwards, where prospects drop out because their objections are never addressed.

There is something else at play. The care market in the Benelux is relatively small and easy to survey. Your audience of hospitals, care groups, insurers and specialised clinics is finite, and the people inside it know each other. Reputation travels fast. That means you cannot hide behind volume: every contact counts, and a bad experience or an overly aggressive campaign can turn against you. A thoughtful, patient system fits better here than a noisy growth sprint.

Growth marketing as a system, not as an isolated tactic

The core of our approach: growth marketing is not one channel, but the system that drives SEO, content, CRO, paid and lead generation as a single growth engine. In healthtech that distinction becomes even more important, because no single channel can carry an adoption cycle of months on its own.

Think about how a real deal unfolds. A clinical manager finds you through a search about a specific problem (SEO and content). She reads on, downloads a validation report and stays in your email flow for months (nurturing). Meanwhile, IT recognises your name from an industry webinar (paid and thought leadership). When the project comes up internally, a dossier is already waiting that reassures procurement and the board (sales enablement). None of those steps works in isolation. Together they form a journey.

That is why, at a growth marketing agency, we look at the full system first before we think about isolated campaigns. We map where prospects drop out in your specific adoption cycle, and then build the missing links deliberately. That is something different from switching on a new channel every quarter and hoping.

Clinical validation as a growth lever

In most markets you sell on promises. In healthtech you sell on evidence. That feels like a brake, but you can turn it into your biggest advantage.

Clinical validation, certifications, published research and regulatory compliance are not just legal obligations. They are the arguments your entire funnel revolves around. The difference between healthtech companies that grow and those that stall often comes down to how well they translate that evidence into understandable content.

Concretely, this means: turn every validation moment into a content moment. A completed pilot becomes a case study. A certification becomes an explainer page that addresses exactly what procurement worries about. A frequent question from one clinician becomes an article that convinces the next one. That is how you build a library that prepares the sales conversation before it even takes place.

Important: never overstate. In a market built on trust, one claim that goes too far is enough to lose your credibility. Write precisely, cite your source, and let the evidence do the work. Under-promising and over-delivering is not a tactic here, it is a survival strategy.

Bear in mind too that evidence has a shelf life that grows with your product. As you complete more pilots, gather more customers and earn new certifications, your evidence library gets stronger. So treat that library as a living part of your growth engine, not as a one-off job. Every new reference you add lowers the barrier for the next prospect who hesitates.

Building for multiple decision-makers at once

The biggest thinking error in healthtech marketing is aiming at one persona. In reality, you are facing a buying committee in which every role has its own lens:

• The clinician or care provider wants to know whether it improves patient care and fits the existing workflow.
• IT and security want to know whether it integrates safely and meets the data rules.
• Procurement and finance want to know what it costs, what it returns and what the contract looks like.
• The board wants to know whether it fits the strategy and what risk comes with it.

One message meant to convince them all convinces nobody in the end. Your growth system therefore needs parallel tracks: content and evidence for every role, at the right moment in the journey. This is exactly where thinking about the B2B buying journey with multiple decision-makers and generating structural demand through demand generation reinforce each other.

In practice, this means arming your internal “champion”. That one enthusiastic clinician sells your product inside the organisation when you are not in the room. Give that person the arguments, the evidence and the answers to bring the other decision-makers along. Your marketing then does not only sell to the prospect, it equips the prospect to sell internally.

Measure what counts: pipeline over vanity metrics

With long cycles and high contract values, the temptation is strong to steer on what moves fast: traffic, followers, clicks. But in healthtech that is noise. Ten thousand visitors without a single qualified hospital contact get you nowhere.

Steer instead on signals that genuinely correlate with revenue: qualified demo requests, deals that move a stage forward, accounts where multiple decision-makers get involved, and ultimately signed pipeline. Those numbers move more slowly, but they tell the truth about your growth.

Because the cycle is so long, you also need leading indicators that move earlier: repeat visits from the same organisation, downloads of evidence material, webinar attendance. Those are the early signs that an account is warming up, long before the demo is requested. A well-designed system makes those signals visible, so you know where momentum is building instead of waiting blindly.

This measurement approach also asks for patience from the organisation around you. If the board or investors push for new revenue every month, pressure builds to fall back on vanity metrics that do move fast. So make clear up front which signals to expect in which phase. Anyone who understands that an account warming up today only becomes a contract months from now keeps investing in the links that eventually make that contract possible. Without that shared expectation, you sabotage your own system before it can pay off.

Where you start

You do not have to build everything at once. Start by mapping your actual adoption cycle: which steps does a typical deal go through, who is involved at each moment, and where do accounts drop out? That map immediately shows where your system has gaps.

Then fill the most urgent gaps. Is there no evidence content for procurement? Build that first. Do warm accounts disappear into silence after first contact? Build nurturing. Approach it as one coherent system, not as isolated campaigns, and you get a growth engine that matches the rhythm of the care market.

Want to know what a growth system looks like for your healthtech product? Get in touch with us and we will look together at your adoption cycle, your decision-makers and the links that are still slowing your growth.